Big Data Genome Production 
pharmaphorum
DECEMBER 8, 2022
The advent of biologic therapies in the 1970s along with the decoding of the human genome in 2003 heralded an explosion in pharmaceutical innovation. This has led to an increase in products coming to market with single‑arm Phase 3 data and surrogate endpoints or Phase 2b data, with planned confirmatory data to be released in the future.
pharmaphorum
JUNE 15, 2021
In the consumer world, we have all come to expect speed and interconnectedness, and value personalized products and services tailored to our lifestyles and needs. Every patient, every doctor or nurse, every hospital worker is a human being influenced by their experiences outside of healthcare. One catalyst for this has been the COVID?19
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
SEPTEMBER 18, 2020
Since the mid-1890s, Swedish pharmacists had been discussing the issue of domestic industrial production of pharmaceuticals in Sweden, as opposed to manual preparations by pharmacists. Astra introduced two important product families onto the Swedish market in 1948: penicillin and anaesthetics, initially in the form of Xylocaine.
Pharma Marketing Network
OCTOBER 14, 2024
The rise of big data analytics, artificial intelligence, and machine learning has revolutionized drug discovery, development, and marketing. With advancements in genomics and biotechnology, there is a move towards tailoring treatments to individual patients based on their genetic makeup.
Pharma Marketing Network
OCTOBER 17, 2024
By leveraging data from genomic studies and electronic health records, marketers can identify niche markets and craft messages that speak directly to the needs and concerns of specific patient populations. Moreover, data analytics is playing a critical role in measuring the success of marketing initiatives.
Delveinsight
FEBRUARY 17, 2021
To fulfill the patient’s evolving needs and to provide them with better services, companies worldwide are focusing on delivering new applications and products to the users. The collected data and the genomic studies can play a crucial role in monitoring the symptoms and predicting potential diseases. .
The Pharma Data
JANUARY 4, 2021
Longwood has a robust research department with 7 post doctorates conducting research in molecular biology, microbiology, genomics, cancer biology, and immunology and publishing over 75 publications in different scientific journals in the past 5 years. Barber also serves on Kiromic’s Scientific Advisory Board. About Longwood University.
Expert insights. Personalized for you.
96 
Let's personalize your content